- Exchange: NASDAQ GS
- Sector: Consumer, Non-cyclical
- Industry: Healthcare-Products
- Sub-Industry: Medical Instruments
Snapshot for DexCom Inc (DXCM)
| Open: | 10.4900 | Day's Range: | 10.4900 - 10.8000 | Volume: | 301,524 | Bid: | 10.7800 |
|---|---|---|---|---|---|---|---|
| Previous Close: | 10.4900 | 52wk Range: | 6.7500 - 15.7900 | 1-Yr Rtn: | -29.48% | Ask: | 10.7900 |
Key Statistics for DXCM
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E (12/2012) | - |
| Earnings Per Share (USD) (ttm) | -0.7000 |
| Est. EPS (USD) (12/2012) | -0.7110 |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 739.65 |
| Shares Outstanding (M) | 68.55 |
| Enterprise Value (M USD) (ttm) | 671.31 |
| Enterprise Value/EBITDA (ttm) | - |
| Price/Book (mrq) | 7.3522 |
| Price/Sale (ttm) | 8.7837 |
| Dividend Indicated Gross Yield | 0.0000 |
| Next Earnings Announcement | 08/03/2012 |
More DXCM Key Statistics
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Financials for DXCM
- Operating
- Investing
- Financing (M/USD)
Company Profile & Key Executives for DXCM
DexCom Inc. is a medical device company focused on the design and development of continuous glucose monitoring systems for people with diabetes. The Company has developed a small implantable device that continuously measures glucose levels in subcutaneous tissue just under the skin, and a small external receiver to which the sensor transmits glucose levels at specified intervals.
| Kevin R SayerPresident | Terrance H Gregg "Terry"Chief Executive Officer |
| Steven R PacelliChief Operating Officer | Jorge A ValdesChief Technology Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Links
Top Forex Trading Resources
Advertisement
Advertisement
Advertisements
Rate this Page